Merck & Co. Inc. disclosed in its latest Quarterly Report on Form
10-Q filed with the U.S. Securities and Exchange Commission that
during 2009, the Company anticipates that it will make total
payments of US$3.4 billion into the Vioxx settlement…
provides in-depth news coverage of pending and recently settled lawsuits involving public companies with assets of USD $1 billion or more. Covered litigation topics include tax issues, insurance disputes, labor problems, shareholder suits, antitrust suits, product liability suits, toxic torts, personal injury suits, among others.